Curcumin Prodrug Shows Promise as Cancer Treatment Without Toxic Side Effects
By Shyla Cadogan Curcumin, the biologically active compound found in turmeric, has shown lots of promise in clinical cancer research. A new study from Kyoto University adds more evidence that supports its use in clinical-care settings. Researchers are developing a curcumin prodrug called TBP1901 that…